Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...238239240241242243244245246247248...401402»
  • ||||||||||  Review, Journal:  Muscular Strength and Cardiovascular Disease: AN UPDATED STATE-OF-THE-ART NARRATIVE REVIEW. (Pubmed Central) -  Oct 31, 2021   
    The majority of the studies investigating the role of MusS with cardiometabolic risk, however, are observational studies, not allowing to ultimately determine association versus causation. Importantly, MusS is also essential for the identification of nutritional status and body composition abnormalities, such as frailty and sarcopenia, which are major risk factors for CVD.
  • ||||||||||  Journal:  The muscle biological clock (Pubmed Central) -  Oct 31, 2021   
    Exercise capacity also displays a circadian rhythm. Alterations in biological rhythm, as in shift workers, alter muscle function and are associated with the development of sarcopenia.
  • ||||||||||  Clinical, Review, Journal:  Does sarcopenia affect outcomes in pediatric surgical patients? A scoping review. (Pubmed Central) -  Oct 31, 2021   
    Despite studies showing an association between sarcopenia and negative outcomes in the adult surgical population, there remains a paucity of evidence regarding the impact of sarcopenia on the pediatric population. Future studies are needed to ascertain the relationship between muscle mass and outcomes in pediatric surgical patients.
  • ||||||||||  Clinical, Review, Journal:  Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. (Pubmed Central) -  Oct 31, 2021   
    The exercise program is designed and carried out on a frequent basis within an extensive scheduled time aimed at improving functional performance, aerobic capacity, and healthy conditions. Finally, a combination of exercise training and therapeutic nutrition is powerfully recommended to control sarcopenia in cirrhosis.
  • ||||||||||  Preclinical, Journal:  Gait disturbances and muscle dysfunction in fibroblast growth factor 2 knockout mice. (Pubmed Central) -  Oct 31, 2021   
    MAPK/ ERK1/2 was significantly increased in young and old Fgf2KO. We conclude that Fgf2KO, age-related decreased FGF2 in WT mice, and increased FGF21 in the setting of impaired Fgf2 expression likely contribute to impaired skeletal muscle function and sarcopenia in mice.
  • ||||||||||  Journal:  Diagnostic and therapeutic approach to sarcopenia (Pubmed Central) -  Oct 31, 2021   
    In both cases, causes must be clarified and treatment should be initiated. To differentiate between acute and chronic sarcopenia it is necessary to assess disease progress after a certain period of time.
  • ||||||||||  Clinical, Journal:  Association between Skeletal Mass Indices and Metabolic Syndrome in Brazilian Adults. (Pubmed Central) -  Oct 30, 2021   
    Further studies are needed to determine whether a causal association exists between anorexia and sarcopenia. In adults, the muscle mass assessed from the skeletal mass index adjusted for body weight and body mass index is inversely associated with metabolic syndrome in both sexes.
  • ||||||||||  Journal:  Age-related decline of interferon-gamma responses in macrophage impairs satellite cell proliferation and regeneration. (Pubmed Central) -  Oct 30, 2021   
    Our data provide a global view of age-associated neuromuscular changes in a mouse model of ageing and help to advance understanding of contributing pathways leading to development of sarcopenia. Our study indicates that decline in IFN-γ response in a novel subset of macrophage contributes to satellite cells dysfunctions in aged skeletal muscles and demonstrates that this mechanism can be targeted to restore age-associated myogenesis.
  • ||||||||||  Clinical, Journal:  Sarcopenia and low muscle radiodensity associate with impaired FEV in allogeneic haematopoietic stem cell transplant recipients. (Pubmed Central) -  Oct 30, 2021   
    Lumbar or thoracic CT images are useful for body composition assessment in this population and reveal high rates of sarcopenia, similar to those reported in very elderly patients. Reduced muscle mass and radiodensity associate with impaired FEV even after adjustment for clinical covariables including co-morbidities, performance status, disease risk, and mild intrinsic pulmonary disease (chronic obstructive pulmonary disease) defined by spirometry.
  • ||||||||||  Preclinical, Journal:  Cancer cachexia in a mouse model of oxidative stress. (Pubmed Central) -  Oct 30, 2021   
    A close association between osteoporosis and sarcopenia was documented for the first time in PD, which has important implications for clinical management and future research. Oxidative stress does not exacerbate cancer-induced muscle loss; however, cancer cachexia may accelerate NMJ disruption.
  • ||||||||||  Preclinical, Journal:  Differential effects of right and left heart failure on skeletal muscle in rats. (Pubmed Central) -  Oct 30, 2021   
    Most of the catabolic changes were observed in soleus or gastrocnemius muscle rather than in the constantly active diaphragm. Mitochondrial dysfunction and up-regulation of myostatin were identified as the earliest signs of skeletal muscle impairment.
  • ||||||||||  Clinical, Journal:  Associations of combined genetic and epigenetic scores with muscle size and muscle strength: a pilot study in older women. (Pubmed Central) -  Oct 30, 2021   
    Mitochondrial dysfunction and up-regulation of myostatin were identified as the earliest signs of skeletal muscle impairment. Our results improve the understanding of inter-individual variance in muscular characteristics of older women and suggest a possible application of a sarcopenia-driven methylation score to muscle strength estimation in older women while the combination with a genetic score still needs to be further studied.
  • ||||||||||  Journal, HEOR:  Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL questionnaire. (Pubmed Central) -  Oct 30, 2021   
    These associations require further examination to understand causality and mechanisms of interaction, to inform potential strategies targeting the gut microbiota as a novel intervention for anorexia of ageing and sarcopenia. The SarQoL questionnaire has adequate clinimetric properties for use with frail patients in clinical practice and trials and could provide data that are more appropriate and detailed than the generic questionnaires currently used.
  • ||||||||||  Journal:  Micronutrients and sarcopenia: current perspectives. (Pubmed Central) -  Oct 30, 2021   
    Renin-angiotensin system inhibition is associated with a lower prevalence of muscle wasting in HF patients independently of established risk factors. No abstract available
  • ||||||||||  niclosamide / Generic mfg., dexamethasone / Generic mfg.
    Journal:  Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy. (Pubmed Central) -  Oct 30, 2021   
    Overall, these results suggest that niclosamide may not be a suitable repurposing drug for glucocorticoid-induced skeletal muscle atrophy or cancer cachexia. Nevertheless, niclosamide may be employed as a compound to study mechanisms regulating myogenesis and catabolic pathways in skeletal muscle.
  • ||||||||||  Biomarker, Clinical, Journal:  Clinical and biomarker assessment of frailty in liver transplantation. (Pubmed Central) -  Oct 30, 2021   
    A comprehensive, validated algorithm for detecting and quantifying frailty specific to liver disease would allow for standardization and facile application in the clinical setting. Early diagnosis is key for timely intervention and improved patient outcomes.